A1 Refereed original research article in a scientific journal

Surgical complications after minimally invasive oesophagectomy compared to open oesophagectomy for oesophageal cancer: A population-based, nationwide study in Finland




AuthorsSirviö, Ville E.J.; Räsänen, Jari V.; Helminen, Olli; Helmiö, Mika; Huhta, Heikki; Kallio, Raija; Koivukangas, Vesa; Kokkola, Arto; Lietzen, Elina; Meriläinen, Sanna; Pohjanen, Vesa-Matti; Rantanen, Tuomo; Ristimäki, Antti; Saarnio, Juha; Sihvo, Eero; Tyrväinen, Tuula; Uimonen, Mikko; Valtola, Antti; Kauppila, Joonas H.

PublisherElsevier

Publication year2025

JournalEJSO - European Journal of Surgical Oncology

Journal name in sourceEuropean Journal of Surgical Oncology

Article number110093

Volume51

Issue7

ISSN0748-7983

eISSN1532-2157

DOIhttps://doi.org/10.1016/j.ejso.2025.110093

Web address https://doi.org/10.1016/j.ejso.2025.110093

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/492312756


Abstract

Introduction: Evidence on the safety of minimally invasive oesophagectomy (MIO) compared to open oesophagectomy (OO) in nationwide practice is lacking. The aim of this study was to compare surgical complications after MIO and OO in a nationwide, population-based, unselected cohort.

Materials and methods: Descriptive statistics were used to report complications and complication categories defined by the Oesophagectomy Complications Consensus Group, major complications, reoperations and 90-day mortality in all patients undergoing MIO and OO in Finland during 2007–2016. Main outcomes were compared using logistic regression, adjusting for confounding.

Results: Out of 699 patients, 295 (42 %) underwent MIO and 404 (58 %) underwent OO. Rates of anastomotic leakage (10 % vs 14 %, OR 0.47 (0.25–0.89)), intrathoracic abscesses (3 % vs 9 %, OR 0.13 (0.05–0.46)), major complications (35 % vs 47 %, OR 0.39 (0.25–0.60)) and reoperations (18 % vs 26 %, OR 0.43 (0.26–0.73)) were lower with MIO. Rates of pneumonia (16 % vs 27 %, OR 0.62 (0.38–1.03)), intra-abdominal abscesses (0.7 % vs 3.0 %, OR 0.20 (0.04–1.13)) and 90-day mortality (3.1 % vs 6.7 %, HR 0.48 (0.18–1.26)) were lower with MIO, but non-significant after adjustment. Pulmonary complications (36 % vs 46 %, OR 0.63 (0.41–0.96)) and infectious complications (11 % vs 22 %, OR 0.41 (0.23–0.73)) were less common with MIO, while rates of cardiac, gastrointestinal, urologic, thromboembolic, and neurologic complications were similar.

Conclusion: This study suggests a significant reduction in various surgical complications in patients undergoing MIO compared to OO and that implementing MIO into nationwide practice can be done safely.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
This work was supported by research grants from Mary&Georg C. Ehrnrooth Foundation, Orion Research Foundation, Sigrid Jusélius Foundation, The Finnish Cancer Foundation and Päivikki and Sakari Sohlberg Foundation. The sources of funding did not have a role in any part of this research, including study design, data acquisition, data analysis and interpretation, manuscript preparation and submission for publication.


Last updated on 2025-17-06 at 13:51